Eman Y. Santali - Concepedia

Author

Eman Y. Santali

Taif University ORCID

Also Known As

E. Santali, Eman Santali, Eman Y Santali, Eman Y. Santali, Faizul Azam, Santali, Eman Yousef

Publications

585

Citations

H-Index

Concepts

All Affiliations

Taif University Beni-Suef University Helwan University Al-Azhar University Damietta University

About

Eman Y. Santali is an author at Taif University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	238
2	Engineering	3	3	98
3	Biochemistry	3	3	92
4	Natural Sciences	2	2	66
5	Biostatistics	1	1	26

Eman Y. Santali

Publications

476

Citations

H-Index

Page 1

	Year	Citations
Novel piperazine–chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation Marwa F. Ahmed, Eman Y. Santali, Radwan El‐Haggar Journal of Enzyme Inhibition and Medicinal Chemistry	2020	64
Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4′-methylmethcathinone (mephedrone): A new “legal high” Eman Y. Santali, Anna‐Karina Cadogan, Niamh Nic Daéid, Journal of Pharmaceutical and Biomedical Analysis Derivative (Chemistry)Pharmaceutical ChemistryEngineeringMedicineValidated Methods	2011	60
Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients Naveed Ahmed, Madiha Khan, Waqas Saleem, Antibiotics	2022	44
Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management Amany Belal, Mohamed A. Elanany, Eman Y. Santali, Molecules Ocular DiseaseBioorganic ChemistryTheir PotentialDermatologyChemical Biology	2022	44
Ligand-based design, synthesis, computational insights, and <i>in vitro</i> studies of novel <i>N</i> -(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	41
Isolation, Characterization and Anticancer Activity of Two Bioactive Compounds from Arisaema flavum (Forssk.) Schott Sobia Nisa, Yamin Bibi, Saadia Masood, Molecules New DrugMedicinal ChemistryMedicineCrude ExtractHerbal Medicine	2022	32
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study Mahmoud M. A. Elsayed, Moustafa O. Aboelez, Mohamed S. Mohamed, Pharmaceutics	2022	31
Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies Marwa F. Ahmed, Eman Y. Santali, Eman M. Mohi El-Deen, Bioorganic Chemistry Medicinal ChemistryPyridazine DerivativesPotential Egfr InhibitorsMedicineRational Drug Design	2020	30
Greenness Assessment of Chromatographic Methods Used for Analysis of Empagliflozin: A Comparative Study Eman Y. Santali, Ibrahim A. Naguib, Abdullah Mohammed Alshehri, Separations EngineeringGreen ChemistryGreenness AssessmentGreen MethodologyGreenness Behavior	2022	26
Discovery of pyridine- sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers Marwa F. Ahmed, Eman Y. Santali Bioorganic Chemistry Medicinal ChemistryMedicinePyridine- Sulfonamide HybridsNew ScaffoldPotential Vegfr-2 Inhibitors	2021	24

Page 1